» Articles » PMID: 30785915

Machine Learning Models for Predicting Post-cystectomy Recurrence and Survival in Bladder Cancer Patients

Overview
Journal PLoS One
Date 2019 Feb 21
PMID 30785915
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Currently in patients with bladder cancer, various clinical evaluations (imaging, operative findings at transurethral resection and radical cystectomy, pathology) are collectively used to determine disease status and prognosis, and recommend neoadjuvant, definitive and adjuvant treatments. We analyze the predictive power of these measurements in forecasting two key long-term outcomes following radical cystectomy, i.e., cancer recurrence and survival. Information theory and machine learning algorithms are employed to create predictive models using a large prospective, continuously collected, temporally resolved, primary bladder cancer dataset comprised of 3503 patients (1971-2016). Patient recurrence and survival one, three, and five years after cystectomy can be predicted with greater than 70% sensitivity and specificity. Such predictions may inform patient monitoring schedules and post-cystectomy treatments. The machine learning models provide a benchmark for predicting oncologic outcomes in patients undergoing radical cystectomy and highlight opportunities for improving care using optimal preoperative and operative data collection.

Citing Articles

How modulation of the tumor microenvironment drives cancer immune escape dynamics.

Shrestha P, Ghoreyshi Z, George J Sci Rep. 2025; 15(1):7308.

PMID: 40025156 PMC: 11873109. DOI: 10.1038/s41598-025-91396-z.


AI predicting recurrence in non-muscle-invasive bladder cancer: systematic review with study strengths and weaknesses.

Abbas S, Shafik R, Soomro N, Heer R, Adhikari K Front Oncol. 2025; 14():1509362.

PMID: 39839785 PMC: 11746116. DOI: 10.3389/fonc.2024.1509362.


Survival After Radical Cystectomy for Bladder Cancer: Development of a Fair Machine Learning Model.

Carbunaru S, Neshatvar Y, Do H, Murray K, Ranganath R, Nayan M JMIR Med Inform. 2024; 12:e63289.

PMID: 39671594 PMC: 11694706. DOI: 10.2196/63289.


Artificial intelligence application in the diagnosis and treatment of bladder cancer: advance, challenges, and opportunities.

Ma X, Zhang Q, He L, Liu X, Xiao Y, Hu J Front Oncol. 2024; 14:1487676.

PMID: 39575423 PMC: 11578829. DOI: 10.3389/fonc.2024.1487676.


Applications of artificial intelligence in urologic oncology.

Pak S, Park S, Park J, Cho S, Lee Y, Ahn H Investig Clin Urol. 2024; 65(3):202-216.

PMID: 38714511 PMC: 11076794. DOI: 10.4111/icu.20230435.


References
1.
Vickers A, Cronin A, Kattan M, Gonen M, Scardino P, Milowsky M . Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach. Cancer. 2009; 115(23):5460-9. PMC: 2785133. DOI: 10.1002/cncr.24615. View

2.
Herr H, Faulkner J, Grossman H, Natale R, White R, Sarosdy M . Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol. 2004; 22(14):2781-9. DOI: 10.1200/JCO.2004.11.024. View

3.
Stein J, Lieskovsky G, Cote R, Groshen S, Feng A, Boyd S . Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001; 19(3):666-75. DOI: 10.1200/JCO.2001.19.3.666. View

4.
Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon A, Resnick M . Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. Eur Urol. 2015; 69(2):300-10. DOI: 10.1016/j.eururo.2015.08.037. View

5.
Butte A, Kohane I . Mutual information relevance networks: functional genomic clustering using pairwise entropy measurements. Pac Symp Biocomput. 2000; :418-29. DOI: 10.1142/9789814447331_0040. View